Exclusive to subscribersYou can now gift articles
Alzheimer’s drug that modestly slows disease OK’d by FDA
U.S. health officials approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and doctors will have to weigh.